Transplantation as disease modifying therapy in adults with inherited metabolic disorders
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Inherited Metabolic Disease"
DOI: 10.1007/s10545-018-0141-z
Abstract: Transplantation is an established disease modifying therapy in selected children with certain inherited metabolic diseases (IMDs). Transplantation of hematopoietic stem cells or solid organs can be used to partially correct the underlying metabolic defect, address… read more here.
Keywords: disease modifying; disease; inherited metabolic; transplantation ... See more keywords
SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Neurology and Neurosurgery"
DOI: 10.1016/j.clineuro.2020.106451
Abstract: At the end of 2019, the COVID-19 pandemic began, which at the time of writing continues to be a serious problem for many areas of medicine, including neurology. Since patients with multiple sclerosis (MS) often… read more here.
Keywords: neurology; disease modifying; disease; multiple sclerosis ... See more keywords
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study.
Sign Up to like & getrecommendations! Published in 2019 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2019.01.003
Abstract: BACKGROUND Exposure to disease-modifying therapy (DMT) during early pregnancy in women with relapsing-remitting MS (RRMS) may be increasing. OBJECTIVE To retrospectively determine incidence of pregnancy, DMT exposure and pregnancy outcomes in women with RRMS. METHODS… read more here.
Keywords: pregnancy; exposure; disease modifying; incidence pregnancy ... See more keywords
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
Sign Up to like & getrecommendations! Published in 2021 at "Developmental Medicine and Child Neurology"
DOI: 10.1111/dmcn.14831
Abstract: Half a century ago, Harry Angelman reported three patients with overlapping clinical features, now well known as Angelman syndrome. Angelman syndrome is caused by mutations affecting the maternally inherited UBE3A gene, which encodes an E3‐ubiquitin… read more here.
Keywords: modifying therapy; therapy angelman; disease modifying; angelman syndrome ... See more keywords
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations
Sign Up to like & getrecommendations! Published in 2024 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/17562864241233044
Abstract: Background: Treatment guidelines recommend early disease-modifying therapy (DMT) initiation after diagnosis of multiple sclerosis (MS). Multinational comparative studies that assess time to DMT initiation in MS may allow detection of barriers inherent to healthcare systems… read more here.
Keywords: initiation; time; time dmt; modifying therapy ... See more keywords
Initial High-Efficacy Disease-Modifying Therapy in Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Neurology"
DOI: 10.1212/wnl.0000000000201391
Abstract: In the Research Article “Initial High-Efficacy Disease-Modifying Therapy in Multiple Sclerosis: A Nationwide Cohort Study” by Buron et al.,1 2 authors were mistakenly omitted from the final manuscript. Dr. Danny Bech, MD, should appear as… read more here.
Keywords: therapy multiple; high efficacy; modifying therapy; disease modifying ... See more keywords
Inequities in the Use of Disease-Modifying Therapy Among Adults Living With Multiple Sclerosis in Urban and Rural Areas in Alberta, Canada
Sign Up to like & getrecommendations! Published in 2025 at "Neurology"
DOI: 10.1212/wnl.0000000000210251
Abstract: Objectives To compare disease-modifying therapy (DMT) use between people living with multiple sclerosis (pwMS) who resided in rural vs urban areas. Methods This retrospective cohort study used population-level individually linked administrative data to identify pwMS… read more here.
Keywords: multiple sclerosis; therapy; modifying therapy; disease modifying ... See more keywords
Polyphenols as the Potential Disease-modifying Therapy in Cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Anti-cancer agents in medicinal chemistry"
DOI: 10.2174/1871520622666220201105204
Abstract: BACKGROUND Disease-modifying therapy in cancer can be defined as long-term treatment that has a beneficial outcome on the course of cancer, affecting the underlying pathophysiology. The anticancer potential of polyphenols is widely studied. However, there… read more here.
Keywords: therapy cancer; disease; modifying therapy; disease modifying ... See more keywords